Trial Profile
A Phase 2, Randomized, Double-blind, Placebo-controlled Study of TAT4 Gel for the Reduction of Nasolabial Folds
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Jan 2018
Price :
$35
*
At a glance
- Drugs TAT 4 (Primary)
- Indications Nasolabial fold
- Focus Therapeutic Use
- Sponsors Topokine Therapeutics
- 03 Feb 2016 New trial record